Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Manning

Showing results (641-650 of 673) with videos related to

Pageof 68
Sort By:
Blood|October 2, 2004
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the diseaseWalter Fiedler, Hubert Serve, Hartmut Döhner, et al.
Blood|January 18, 2003
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivoAnne-Marie O'Farrell, Tinya J Abrams, Helene A Yuen, et al.
The Science of the Total Environment|February 19, 2024
Equipping for risk: Lessons learnt from the UK shale-gas experience on assessing environmental risks for the future geoenergy use of the deep subsurfaceP L Smedley, G Allen, B J Baptie, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 4, 2022
Distinct Stress-Dependent Signatures of Cellular and Extracellular tRNA-Derived Small RNAsGuoping Li, Aidan C Manning, Alex Bagi, et al.
Neuro-Oncology|August 21, 2014
Periostin is a novel therapeutic target that predicts and regulates glioma malignancyAndrei M Mikheev, Svetlana A Mikheeva, Andrew D Trister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patientsAnne-Marie O'Farrell, James M Foran, Walter Fiedler, et al.
Global Change Biology|October 23, 2019
Which practices co-deliver food security, climate change mitigation and adaptation, and combat land degradation and desertification?Pete Smith, Katherine Calvin, Johnson Nkem, et al.
BMJ Paediatrics Open|September 2, 2022
Early mobilisation and rehabilitation in the PICU: a UK surveyJacqueline Y Thompson, Julie C Menzies, Joseph C Manning, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 7, 2023
Climate-driven variability of the Southern Ocean CO<sub>2</sub> sinkN Mayot, C Le Quéré, C Rödenbeck, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 8, 2022
Outcomes in Pediatric Thyroidectomy: Results From a Multinational, Multi-institutional DatabaseMatthew Maksimoski, Andrew J Bauer, Ken Kazahaya, et al.
Pageof 68

Showing results (641-650 of 673) with videos related to

Sort By:
Pageof 68
Blood|October 2, 2004
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the diseaseWalter Fiedler, Hubert Serve, Hartmut Döhner, et al.
Blood|January 18, 2003
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivoAnne-Marie O'Farrell, Tinya J Abrams, Helene A Yuen, et al.
The Science of the Total Environment|February 19, 2024
Equipping for risk: Lessons learnt from the UK shale-gas experience on assessing environmental risks for the future geoenergy use of the deep subsurfaceP L Smedley, G Allen, B J Baptie, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 4, 2022
Distinct Stress-Dependent Signatures of Cellular and Extracellular tRNA-Derived Small RNAsGuoping Li, Aidan C Manning, Alex Bagi, et al.
Neuro-Oncology|August 21, 2014
Periostin is a novel therapeutic target that predicts and regulates glioma malignancyAndrei M Mikheev, Svetlana A Mikheeva, Andrew D Trister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patientsAnne-Marie O'Farrell, James M Foran, Walter Fiedler, et al.
Global Change Biology|October 23, 2019
Which practices co-deliver food security, climate change mitigation and adaptation, and combat land degradation and desertification?Pete Smith, Katherine Calvin, Johnson Nkem, et al.
BMJ Paediatrics Open|September 2, 2022
Early mobilisation and rehabilitation in the PICU: a UK surveyJacqueline Y Thompson, Julie C Menzies, Joseph C Manning, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|May 7, 2023
Climate-driven variability of the Southern Ocean CO<sub>2</sub> sinkN Mayot, C Le Quéré, C Rödenbeck, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 8, 2022
Outcomes in Pediatric Thyroidectomy: Results From a Multinational, Multi-institutional DatabaseMatthew Maksimoski, Andrew J Bauer, Ken Kazahaya, et al.
Pageof 68